Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | PAM | P19021 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 3/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.52 |
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | PPARD | Q03181 | 6/20 | 0.52 |
| ▸ | PPARA | Q07869 | 6/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL900152 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL905880 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL602197 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL225274 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL2980851 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL337904 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL262930 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL394559 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL8683587 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL222937 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119793684-A | Flotation method of niobium-containing mineral | 中南大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119793683-A | Stepwise enrichment flotation method for niobium ore | 中南大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119462134-A | Preparation method of liquid zirconia for 3D printing | 泰利斯医疗实业(深圳)有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118772803-A | Composite conductive adhesive and preparation method and application thereof | 上海芯陶微新材料有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118558470-A | Method for separating and recovering magnesium-rich minerals from copper-nickel flotation tailings | 金川集团镍钴有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-117839874-A | Method for recycling silicon in crystal silicon cutting waste slurry by adopting floatation | 昆明理工大学 | 2024-04-09 | — | — | CN | claimed |
| CN-114762842-B | Method for extracting lithium carbonate from mixed salt of carbonate and chloride | 中蓝长化工程科技有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-116637724-A | Method for extracting lithium carbonate from low-grade lithium carbonate, potassium chloride and sodium chloride mixed salt | 中蓝长化工程科技有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-116297994-A | Analysis and detection method for alkanolamides with different carbon chains in oilfield produced fluid | 中国科学院兰州化学物理研究所 | 2023-06-23 | — | — | CN | claimed |
| CN-115805059-B | Activated carbon loaded, preparation method and application of activated carbon loaded in treatment of carbon purification furnace waste gas | 山东红点新材料有限公司 | 2023-04-21 | — | — | CN | claimed |
| US-20040105889-A1 | Low viscosity liquid dosage forms | ELAN PHARMA INTERNATIONAL LIMITED | 2004-06-03 | — | — | US | claimed |
| US-20030185869-A1 | Having lysozyme adsorbed onto or associated with the surface of an active agent | ELAN PHARMA INTERNATIONAL LTD. | 2003-10-02 | — | — | US | claimed |
| WO-2003066021-A2 | DRUG NANOPARTICLES WITH LYSOZYME SURFACE STABILISER | ELAN PHARMA INTERNATIONAL, LTD. (IE) | 2003-08-14 | — | — | WO | claimed |
| CN-1105496-C | Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using same | BUCKMAN LABOR INC (US) | 2003-04-16 | — | — | CN | claimed |
| CN-1270498-A | Synergistic antimicrobial compositions containing dodecylmorpholine or a salt thereof and dodecylamine or a salt thereof | BUCKMAN LABOR INC (US) | 2000-10-18 | — | — | CN | claimed |
| CN-1210442-A | Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using same | BUCKMAN LABOR INC (US) | 1999-03-10 | — | — | CN | claimed |
| EP-0479908-A4 | IMPROVED AQUEOUS CLEANER/DEGREASER COMPOSITIONS | — | 1992-06-17 | — | — | EP | claimed |
| EP-0479908-A1 | IMPROVED AQUEOUS CLEANER/DEGREASER COMPOSITIONS. | BUCKEYE INT (US) | 1992-04-15 | — | — | EP | claimed |
| WO-1991000336-A1 | IMPROVED AQUEOUS CLEANER/DEGREASER COMPOSITIONS | BUCKEYE INTERNATIONAL, INC. (US) | 1991-01-10 | — | — | WO | claimed |
| US-4836870-A | Emulsion-type explosive compositions | MITCHELL CHEMICAL CO. (US) | 1989-06-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030185869-A1 | Having lysozyme adsorbed onto or associated with the surface of an active agent | LPO, LCT, CTSA | DGKA 3754/4885LMNA 430/4885PAM 2569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.